Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells

Int J Oncol. 2009 Oct;35(4):717-24. doi: 10.3892/ijo_00000384.

Abstract

Baicalein has been reported to induce growth-inhibitory activity in vitro in human cancer cells; however, the molecular mechanism of action is not completely understood. A pharmacological dose (10-100 microM) of baicalein exerted a cytotoxic effect on human hepatoma J5 cells resulting in G2/M arrest and apoptosis. In addition to cytotoxicity in J5 cells, several apoptotic events including mitochondrial cytochrome c release, activation of caspase-9 and -3 occurred. Baicalein induced AIF and Endo G release from mitochondria indicating that baicalein stimulates apoptosis through the caspase-independent pathway, while undergoing apoptosis, there was a remarkable accumulation of G2/M cells. Also, the ratio of Bax/Bcl-2 was increased leading to changes in mitochondria membrane potential (DeltaPsim) and release of cytochrome c, whereas the baicalein-induced apoptosis was partially abrogated by pretreatment with the pan-caspase inhibitor z-VAD-fmk, the accumulation of G2/M cells remained. These results demonstrate that the cytotoxicity of baicalein in J5 cells is attributable to apoptosis mainly involving G2/M-arrest in an ER-dependent manner, via a mitochondria-dependent caspase pathway and as well as contributions of AIF and Endo G pathways.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis Inducing Factor / metabolism
  • Calcium / metabolism
  • Carcinoma, Hepatocellular / enzymology*
  • Carcinoma, Hepatocellular / pathology
  • Caspase 3 / metabolism*
  • Caspase Inhibitors
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Shape / drug effects
  • Cell Survival / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochromes c / metabolism
  • DNA Damage
  • Dose-Response Relationship, Drug
  • Endodeoxyribonucleases / metabolism
  • Enzyme Activation
  • Flavanones / pharmacology*
  • Humans
  • Liver Neoplasms / enzymology*
  • Liver Neoplasms / pathology
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / enzymology
  • Mitochondria / pathology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects*
  • Time Factors
  • bcl-2-Associated X Protein / metabolism

Substances

  • AIFM1 protein, human
  • Amino Acid Chloromethyl Ketones
  • Antineoplastic Agents, Phytogenic
  • Apoptosis Inducing Factor
  • BAX protein, human
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Flavanones
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • bcl-2-Associated X Protein
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • baicalein
  • Cytochromes c
  • Endodeoxyribonucleases
  • endonuclease G
  • CASP3 protein, human
  • Caspase 3
  • Calcium